Skip to content
DataLookout
Menu

NCT07281781

Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow

StatusRecruiting
PhasePhase 1/2
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Jun 2026 to Jun 2027
    • Eligibility criteria expanded, about 22 words
  2. Minor Secondary endpoints revised (2)v3
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change in Hepcidin Levels
Timeframe: 30 days

Secondary (2)

Change in Hemoglobin Levels
Change From Baseline in Serum Fibrosis Biomarker Concentrations

Arms and interventions

NelfinavirExperimental

Given Orally

Drugs: Nelfinavir

Sites

1 site in 1 country

  • Chao Family Comprehensive Cancer Center, University of California, IrvineOrange, California, United States